Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Peripheral Blood Stem Cell Transplantation 13Tacrolimus 7Busulfan 7fludarabine phosphate 6Mycophenolic Acid 6Methotrexate 6Imatinib Mesylate 6Cyclosporine 6Filgrastim 5Cyclophosphamide 5Whole-Body Irradiation 3Decitabine 3Cytarabine 3ponatinib 2nilotinib 2bosutinib 2aldesleukin 2Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Flow Cytometry 2Etoposide 2Cord Blood Stem Cell Transplantation 2Blood Specimen Collection 2Arsenic Trioxide 2Antilymphocyte Serum 2venetoclax 1vatalanib 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Blast Crisis × Podophyllotoxin × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡